Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4583
Gene Symbol: MUC2
MUC2
0.100 AlteredExpression disease BEFREE IPMTs of adenoma (dysplasia) type exhibited high expression of MUC2 (93%), MUC5AC (97%), and, to a lesser extent, of MUC4 (71%), all of which were also observed in colloid carcinomas associated with IPMTs. 12210083 2002
Entrez Id: 4583
Gene Symbol: MUC2
MUC2
0.100 AlteredExpression disease BEFREE Colorectal mucinous carcinomas are positive for MUC2 expression, whereas MUC2 is down-regulated in non-mucinous adenocarcinomas. 21605079 2011
Entrez Id: 4583
Gene Symbol: MUC2
MUC2
0.100 AlteredExpression disease BEFREE Pancreatic mucinous noncystic (colloid) carcinomas (MNCC) differ from the usual ductal adenocarcinomas in their mucin expression profile and share with many extrapancreatic mucinous carcinomas the expression of MUC2. 12808058 2003
Entrez Id: 4583
Gene Symbol: MUC2
MUC2
0.100 AlteredExpression disease LHGDN MUC2 was expressed in all 25 cases (100%) of mucinous adenocarcinoma of the prostate, irrespective of the Gleason pattern. 18487999 2008
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 AlteredExpression disease BEFREE The cytokeratin, mucin core protein, CDX2, Ki-67 and p53 expression patterns are identical in the xenograft and resected tumour and are consistent with the expected pattern of protein expression for mucinous adenocarcinoma of the appendix. 20586814 2010
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 AlteredExpression disease BEFREE Telomerase activity was not detectable in IPMT-adenomas, but was detected in all 5 IPMT-carcinomas and 3 papillary-mucinous carcinomas. p53 overexpression was not detected in IPMTs, but was detected in 2 (66%) of 3 papillary-mucinous carcinomas, indicating that telomerase is likely to be activated concomitant with carcinogenesis. 12579258 2003
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 AlteredExpression disease BEFREE Additional Trp53 inactivation activates a cell-autonomous epithelial-to-mesenchymal transition program leading to an invasive mucinous adenocarcinoma. 26766588 2016
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 AlteredExpression disease BEFREE Weak hMLH1 expression was correlated to microsatellite instability (P=0.04), negative p53 expression (P=0.005) and mucinous carcinomas (P=0.02). 12469183 2003
Entrez Id: 4583
Gene Symbol: MUC2
MUC2
0.100 AlteredExpression disease BEFREE Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary. 9306958 1997
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
0.080 AlteredExpression disease BEFREE Endometrioid and serous carcinomas showed high expression of Mdm2 and erbB2 while mucinous carcinomas showed low expression. 11351242 2001
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
0.080 AlteredExpression disease BEFREE Rare gastric-type and HPVA mucinous carcinomas displayed HER2 overexpression. 29851704 2018
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
0.080 AlteredExpression disease BEFREE The authors identified HER2 genomic amplification and protein overexpression in 35.3% (6/17) and 29.4% (5/17), respectively, of primary ovarian mucinous carcinomas. 21896578 2011
Entrez Id: 4292
Gene Symbol: MLH1
MLH1
0.070 AlteredExpression disease LHGDN These results suggest that microsatellite-unstable mucinous carcinoma occurring in the elderly shares clinicopathological and molecular features with medullary type poorly differentiated adenocarcinoma and that microsatellite instability with absent hMLH1 expression plays an important role in the development of these two carcinomas. 17316416 2007
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.070 AlteredExpression disease BEFREE Metastatic MC-G had significantly higher stromal p16 expression than primary MC-G. Further, stromal p16 overexpression in MC-G was associated with advanced stage, parametrial invasion, and lymphovascular invasion. 29848709 2018
Entrez Id: 4292
Gene Symbol: MLH1
MLH1
0.070 AlteredExpression disease BEFREE Weak hMLH1 expression was correlated to microsatellite instability (P=0.04), negative p53 expression (P=0.005) and mucinous carcinomas (P=0.02). 12469183 2003
Entrez Id: 4292
Gene Symbol: MLH1
MLH1
0.070 AlteredExpression disease BEFREE Thirty percent of IPMC tumors and 25% of IPMA tumors showed MSI-L. All IPMCs and IPMAs showed normal expression of both hMLH1 and hMSH2. 12448010 2002
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.070 AlteredExpression disease BEFREE The positive rate of p16 protein expression in mucoid carcinoma 10.00% (1/10) was significantly lower than that in poorly differentiated carcinoma 51.22% (21/41), undifferentiated carcinoma 57.69% (15/26) and signet ring cell carcinoma 62.50% (10/16) (P < 0.05). 11819820 2001
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.070 AlteredExpression disease BEFREE Here, we analyzed MUC5AC, MUC6, αGlcNAc, and p16 expression in 9 lesions of mucinous carcinoma, gastric type with minimal deviation adenocarcinoma (GAS-MDA), 5 of GAS with nonMDA (GAS-nonMDA), 14 of typical lobular endocervical gland hyperplasia (LEGH), and 5 of atypical LEGH (33 total lesions).All 33 were MUC5AC-positive. 29845361 2018
Entrez Id: 4292
Gene Symbol: MLH1
MLH1
0.070 AlteredExpression disease BEFREE The prevalence of absent hMLH1 expression was higher in poorly differentiated adenocarcinoma (63%) and mucinous carcinoma (43%) than in well- (8%) and moderately (12%) differentiated adenocarcinomas. 16984616 2006
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.070 AlteredExpression disease BEFREE The positive rate of P16 protein expression in mucoid carcinoma (10%, 1/10) was significantly lower than that in poorly differentiated carcinoma (51%, 21/41), undifferentiated carcinoma (58%, 15/26) and signet ring cell carcinoma (62%, 10/16) (P<0.05). 15818729 2005
Entrez Id: 4292
Gene Symbol: MLH1
MLH1
0.070 AlteredExpression disease BEFREE MSI (13% of 438 cases) was not associated with survival (rate ratio = 0.97, 95% confidence interval = 0.57-1.64, P = 0.90), although it was related to proximal tumour (P <0.001), poor differentiation and mucinous carcinomas (P <0.001), multiple tumours (P = 0.01) and negative/weak expression of hMLH1 (P = 0.03). 14760116 2004
Entrez Id: 238
Gene Symbol: ALK
ALK
0.060 AlteredExpression disease BEFREE In conclusion, aberrant ALK expression is observed in ovarian serous carcinoma but not in mucinous carcinoma, is independent of gene translocation, and might be associated with progression and prognosis. 27271776 2016
Entrez Id: 115482713
Gene Symbol: H3P10
H3P10
0.060 AlteredExpression disease BEFREE The positive rate of P16 protein expression in mucoid carcinoma (10%, 1/10) was significantly lower than that in poorly differentiated carcinoma (51%, 21/41), undifferentiated carcinoma (58%, 15/26) and signet ring cell carcinoma (62%, 10/16) (P<0.05). 15818729 2005
Entrez Id: 115482713
Gene Symbol: H3P10
H3P10
0.060 AlteredExpression disease BEFREE The positive rate of p16 protein expression in mucoid carcinoma 10.00% (1/10) was significantly lower than that in poorly differentiated carcinoma 51.22% (21/41), undifferentiated carcinoma 57.69% (15/26) and signet ring cell carcinoma 62.50% (10/16) (P < 0.05). 11819820 2001
Entrez Id: 115482713
Gene Symbol: H3P10
H3P10
0.060 AlteredExpression disease BEFREE Here, we analyzed MUC5AC, MUC6, αGlcNAc, and p16 expression in 9 lesions of mucinous carcinoma, gastric type with minimal deviation adenocarcinoma (GAS-MDA), 5 of GAS with nonMDA (GAS-nonMDA), 14 of typical lobular endocervical gland hyperplasia (LEGH), and 5 of atypical LEGH (33 total lesions).All 33 were MUC5AC-positive. 29845361 2018